This inventor holds 38 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Oligonucleotide Chemistry. Top assignees: Hybridon, Inc., Spring Bank Pharmaceuticals, Inc., F-Star Therapeutics, Inc.. Active years: 1997-2026.
Location History:
- Shrewbury, MA (US) (1998)
- Shrewsbury, MA (US) (1997 - 2023)
Company Filing History:
13 out of 98 
9 out of 9 
4 out of 11 Years Active: 1997-2026
Areas of Expertise:
Title: Radhakrishnan P Iyer: Innovator in Therapeutic Compounds
Introduction
Radhakrishnan P Iyer, based in Shrewsbury, MA, is a notable inventor with an impressive portfolio of 35 patents. His work focuses primarily on the development of compounds and compositions relevant to medical treatments, particularly those that facilitate the activation of pattern recognition receptors essential in immune responses.
Latest Patents
Among Radhakrishnan's latest contributions to the field are patents concerning "Compounds, compositions, and methods for the treatment of disease." These patents disclose innovative compounds and compositions designed to activate or induce the expression of pattern recognition receptors such as STING, RIG-I, and MDA5. The methodologies associated with these compounds present promising avenues for therapeutic interventions.
Career Highlights
Radhakrishnan has made significant strides in the pharmaceutical and biotechnology sectors, having worked with reputable companies like Hybridon, Inc. and Spring Bank Pharmaceuticals, Inc. His expertise in the development of therapeutic compounds underscores his role as a key player in advancing medical science through innovation.
Collaborations
Throughout his career, Radhakrishnan has had the privilege of collaborating with leading scientists, including Sudhir Agrawal and Seetharamaiyer Padmanabhan. These partnerships have fostered an environment of shared knowledge and expertise, further enhancing the impact of his inventions in the field of medicine.
Conclusion
Radhakrishnan P Iyer stands out as a pioneering inventor with a strong focus on developing innovative solutions for disease treatment. His extensive patent portfolio and collaborations reflect his commitment to advancing healthcare through targeted pharmaceutical innovations. As he continues to work towards new breakthroughs, the medical community eagerly anticipates the potential implications of his research and inventions.